These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18196665)

  • 1. Stents wars.
    Kremastinos D
    Hellenic J Cardiol; 2007; 48(6):387. PubMed ID: 18196665
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual drug release from stents-will we be happy with thing one and thing two?
    Hehrlein C
    Catheter Cardiovasc Interv; 2007 Nov; 70(6):880. PubMed ID: 18022914
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful use of sirolimus-eluting stents for treatment of ST-elevation acute myocardial infarction caused by left main coronary artery occlusion.
    Bush HS; Strong DE; Novaro GM
    Tex Heart Inst J; 2005; 32(3):421-3. PubMed ID: 16392234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beauty's only skin deep: surface technologies emerge in stenting.
    Schwartz RS
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):408-9. PubMed ID: 14571495
    [No Abstract]   [Full Text] [Related]  

  • 5. [Paclitaxel-eluting stents in treatment of stenoses and chronic occlusions of coronary arteries].
    Maslov LN; Krylov AL
    Angiol Sosud Khir; 2007; 13(3):53-60. PubMed ID: 18382394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
    Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R
    Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An experience of the use of stents with drug coating in patients with long and diffuse coronary artery lesions].
    Matchin IuG; Liakishev AA; Mironova IIu; Savchenko AP; Belenkov Iu
    Kardiologiia; 2007; 47(9):41-6. PubMed ID: 18260927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-digit target vessel revascularization in multivessel coronary interventions with sirolimus-eluting stents: goodbye to coronary bypass grafting.
    Colombo A
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):61-2. PubMed ID: 15343569
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large-size vessels.
    Sharma SK
    Catheter Cardiovasc Interv; 2005 May; 65(1):10-6. PubMed ID: 15810018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient sirolimus serum levels after implantation of a sirolimus eluting stent in an infant.
    Riede FT; Schneider P; Dähnert I
    Clin Res Cardiol; 2007 Jul; 96(7):508-10. PubMed ID: 17453134
    [No Abstract]   [Full Text] [Related]  

  • 11. Sirolimus-eluting stents. (The results of the five-year use for the treatment of coronary artery disease).
    Krylov AL
    Angiol Sosud Khir; 2006; 12(4):71-82. PubMed ID: 17679960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of drug-coated stents to treat coronary bifurcation lesions].
    Savchenko AP; Rudenko BA
    Vestn Rentgenol Radiol; 2005; (5):17-24. PubMed ID: 16583799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of late incomplete stent apposition: a comparison among bare-metal stents, intracoronary radiation and sirolimus-eluting stents.
    Miyazawa A; Tsujino I; Ako J; Shimada Y; Courtney BK; Sakurai R; Nakamura M; Okura H; Waseda K; Honda Y; Fitzgerald PJ
    J Invasive Cardiol; 2007 Dec; 19(12):515-8. PubMed ID: 18180522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New horizon of bioabsorbable stent.
    Saito S
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):595-6. PubMed ID: 16284981
    [No Abstract]   [Full Text] [Related]  

  • 15. Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model.
    Berg R; Aragon J; Royter V; Shanley JF; Cogert G; Vermani R; Kar S; Eigler N; Litvack F
    Catheter Cardiovasc Interv; 2007 Nov; 70(6):871-9. PubMed ID: 17932889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems.
    Young JJ
    Rev Cardiovasc Med; 2007; 8 Suppl 1():S3-10. PubMed ID: 17401309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late stent thrombosis: problem or not?
    Somberg J; Weinberger J
    Am J Cardiol; 2007 Apr; 99(7):1020-3. PubMed ID: 17398205
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolic acid-eluting stent and the ABC's of stent-based immunosuppressive therapies for the prevention of restenosis.
    Carter AJ
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):496-8. PubMed ID: 16283681
    [No Abstract]   [Full Text] [Related]  

  • 19. Six-months patency of three long drug eluting stents documented by surveillance coronary multi-detector computed tomography (MDCT).
    Movahed MR
    Clin Res Cardiol; 2006 Nov; 95(11):605-9. PubMed ID: 16897140
    [No Abstract]   [Full Text] [Related]  

  • 20. Carotid artery in-stent restenosis resolved with drug-eluting stenting.
    Iancu A; Lazar A
    J Invasive Cardiol; 2007 Jul; 19(7):315. PubMed ID: 17620678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.